Literature DB >> 7081325

Phencyclidine: its transfer across the placenta as well as into breast milk.

J M Nicholas, J Lipshitz, E C Schreiber.   

Abstract

Phencyclidine (PCP) is a dangerous and unpredictable drug which is widely abused among young people. Acute placental transfer of this drug was studied in pregnant rabbits and mice where it was shown to cross the placenta readily. Rabbit fetal levels of radioactivity reached their peak 2 hours after parenteral administration of PCP to the doe. In the mouse, where actual PCP levels were determined, there was a tenfold higher concentration of PCP in fetal tissue than in maternal blood. In lactating mice, the drug was found to cross rapidly into breast milk where it reached concentrations which were 10 times that of plasma. As PCP may be teratogenic and has been shown to be harmful to the infant during the postnatal period, those treating pregnant women should be aware to these possible routes of exposure for the developing infant and should counsel their patients accordingly.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7081325     DOI: 10.1016/0002-9378(82)90643-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Prenatal NMDA receptor antagonism impaired proliferation of neuronal progenitor, leading to fewer glutamatergic neurons in the prefrontal cortex.

Authors:  Kazuya Toriumi; Akihiro Mouri; Shiho Narusawa; Yuki Aoyama; Natsumi Ikawa; Lingling Lu; Taku Nagai; Takayoshi Mamiya; Hyoung-Chun Kim; Toshitaka Nabeshima
Journal:  Neuropsychopharmacology       Date:  2012-01-18       Impact factor: 7.853

Review 2.  Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations.

Authors:  G Pons; E Rey; I Matheson
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

Review 3.  Effects of Perinatal Exposure to Ketamine on the Developing Brain.

Authors:  Hoi Man Cheung; David Tai Wai Yew
Journal:  Front Neurosci       Date:  2019-02-22       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.